Caraco Pharmaceutical Laboratories Wins FDA Approval To Market Generic Version Of Adipex-P

Free Trial!
Today’s Best Stocks To Trade!

Caraco Pharmaceutical Laboratories Wins FDA Approval To Market Generic Version Of Adipex-P - Quick Facts

Wednesday, August 22, 2007; Posted: 01:06 PM

7 Stocks You Need To Know For Tomorrow -- Free Newsletter

(RTTNews) - Caraco Pharmaceutical Laboratories, Ltd., (CPD | charts | news | PowerRating) on Wednesday said that the US Food and Drug Administration gave final approval for the company's Abbreviated New Drug Application for Phentermine Hydrochloride Tablets USP, 37.5 mg. Phentermine HCl is indicated only as short-term monotherapy for the management of exogenous obesity.

According to the company, its generic Phentermine HCl is the bioequivalent to Adipex-P, a registered trademark of TEVA Pharmaceuticals USA, Inc.

Morning Coffee with TradingMarkets -- Free Newsletter

More News: Market Updates | Stock Alerts | All Trading News | Stock Index

PREMIER SPONSORED LINKS

TRADE CENTER

Please call 1-213-955-5858 ext. 1

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

RELATED SITES